{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:57:30Z","timestamp":1765612650211,"version":"3.48.0"},"reference-count":30,"publisher":"BMJ","issue":"9","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2014,7,14]]},"published-print":{"date-parts":[[2014,9]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Post-thrombotic syndrome (PTS) is a serious complication of deep vein thrombosis (DVT) of the leg that affects 20\u201350% of patients. Once a patient experiences PTS there is no treatment that effectively reduces the debilitating complaints. Two randomised controlled trials showed that elastic compression stocking (ECS) therapy after DVT for 24\u2005months can reduce the incidence of PTS by 50%. However, it is unclear whether all patients benefit to the same extent from ECS therapy or what the optimal duration of therapy for individual patients should be. ECS therapy is costly, inconvenient, demanding and sometimes even debilitating. Tailoring therapy to individual needs could save substantial costs. The objective of the IDEAL DVT study, therefore, is to evaluate whether tailoring the duration of ECS therapy on signs and symptoms of the individual patient is a safe and effective method to prevent PTS, compared with standard ECS therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>A multicentre, single-blinded, allocation concealed, randomised, non-inferiority trial. A total of 864 consecutive patients with acute objectively documented proximal DVT of the leg are randomised to either standard duration of 24\u2005months or tailored duration of ECS therapy following an initial therapeutic period of 6\u2005months. Signs and symptoms of PTS are recorded at regular clinic visits. Furthermore, quality of life, costs, patient preferences and compliance are measured. The primary outcome is the proportion of patients with PTS at 24\u2005months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Based on current knowledge the standard application of ECS therapy is questioned. The IDEAL DVT study will address the central questions that remain unanswered: Which individual patients benefit from ECS therapy and what is the optimal individual treatment duration? Primary ethics approval was received from the Maastricht University Medical Centre.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Results of the study will be disseminated via peer-reviewed publications and presentations at scientific conferences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>NCT01429714 and NTR 2597.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2014-005265","type":"journal-article","created":{"date-parts":[[2014,9,5]],"date-time":"2014-09-05T01:49:29Z","timestamp":1409881769000},"page":"e005265","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":21,"title":["The IDEAL DVT study, individualised duration elastic compression therapy against long-term duration of therapy for the prevention of post-thrombotic syndrome: protocol of a randomised controlled trial"],"prefix":"10.1136","volume":"4","author":[{"given":"Arina J","family":"ten Cate-Hoek","sequence":"first","affiliation":[{"name":"Laboratory for Thrombosis and Hemostasis, Maastricht University Medical Centre, Maastricht, The Netherlands"},{"name":"Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annemieke C","family":"Bouman","sequence":"additional","affiliation":[{"name":"Laboratory for Thrombosis and Hemostasis, Maastricht University Medical Centre, Maastricht, The Netherlands"},{"name":"Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela A","family":"Joore","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht University Medical Centre, Maastricht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Prins","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht University Medical Centre, Maastricht, The Netherlands"},{"name":"Department of Epidemiology, Care and Public Health Research Institutes, Maastricht University, Maastricht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"ten Cate","sequence":"additional","affiliation":[{"name":"Laboratory for Thrombosis and Hemostasis, Maastricht University Medical Centre, Maastricht, The Netherlands"},{"name":"Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2014,9,4]]},"reference":[{"key":"2025121223531995000_4.9.e005265.1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-149-10-200811180-00004"},{"key":"2025121223531995000_4.9.e005265.2","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-009-0336-2"},{"key":"2025121223531995000_4.9.e005265.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07601.x"},{"key":"2025121223531995000_4.9.e005265.4","first-page":"423","article-title":"The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients","volume":"82","author":"Prandoni","year":"1997","journal-title":"Haematologica"},{"key":"2025121223531995000_4.9.e005265.5","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-126-6-199703150-00006"},{"key":"2025121223531995000_4.9.e005265.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)12215-7"},{"key":"2025121223531995000_4.9.e005265.7","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-141-4-200408170-00004"},{"key":"2025121223531995000_4.9.e005265.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2010.01.089"},{"key":"2025121223531995000_4.9.e005265.9","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.17.2105"},{"key":"2025121223531995000_4.9.e005265.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2008.01.008"},{"key":"2025121223531995000_4.9.e005265.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61902-9"},{"key":"2025121223531995000_4.9.e005265.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(98)00097-3"},{"key":"2025121223531995000_4.9.e005265.13","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8510(96)00822-6"},{"key":"2025121223531995000_4.9.e005265.14","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.jclinepi.2005.10.016","article-title":"VEINES-QOL\/Sym questionnaire was a reliable and valid disease-specific quality of life measure for deep venous thrombosis","volume":"59","author":"Kahn","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"2025121223531995000_4.9.e005265.15","unstructured":"Brouwer W . Handleiding voor het gebruik van PRODISQ versie 2.1 (PROductivity and DISease Questionnaire). Een modulaire vragenlijst over de relatie tussen ziekte en productiviteitskosten. Toepasbaar bij economische evaluaties van gezondheidszorgprogramma's voor pati\u00ebnten en werknemers. Rotterdam\/Maastricht 2004."},{"key":"2025121223531995000_4.9.e005265.16","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1055\/s-0037-1613229","article-title":"The diagnostic value of compression ultrasonography in patients with suspected recurrent deep vein thrombosis","volume":"88","author":"Prandoni","year":"2002","journal-title":"Thromb Haemost"},{"key":"2025121223531995000_4.9.e005265.17","doi-asserted-by":"crossref","unstructured":"Lancaster K . A new approach to consumer theory. J Polit Econ 1966 (74):132\u201357.","DOI":"10.1086\/259131"},{"key":"2025121223531995000_4.9.e005265.18","unstructured":"CBO. CBO Richtlijn Diagnostiek, preventie en behandeling van veneuze trombo-embolie en secundaire preventie van arteriele trombose. Utrecht: Kwaliteitsinstituut voor de Gezondheidszorg CBO, 2008."},{"key":"2025121223531995000_4.9.e005265.19","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0652"},{"key":"2025121223531995000_4.9.e005265.20","first-page":"61","article-title":"Aspects of cost effectiveness in therapy of acute leg\/pelvic vein thrombosis","volume":"149","author":"Blattler","year":"1999","journal-title":"Wien Med Wochenschr"},{"key":"2025121223531995000_4.9.e005265.21","unstructured":"Gelderblom GJ Hagedoorn-Meuwissen EAV . Kousen uittrekhulpmiddel Easy-Lever. Een onderzoek naar bruikbaarheid, effecten en belemmeringen, in opdracht van ZonMw. 2005(juni)."},{"key":"2025121223531995000_4.9.e005265.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2007.07.014"},{"key":"2025121223531995000_4.9.e005265.23","unstructured":"Villalta S Bagatella P Picolli A , et al. Assessment of validity and reproducibility of a clinical scale for the post thrombotic syndrome. Haemostasis 1994 (24):158a."},{"key":"2025121223531995000_4.9.e005265.24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03294.x"},{"key":"2025121223531995000_4.9.e005265.25","doi-asserted-by":"publisher","DOI":"10.1046\/j.1524-4733.2003.00234.x"},{"key":"2025121223531995000_4.9.e005265.26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03627.x"},{"key":"2025121223531995000_4.9.e005265.27","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-6296(01)00130-8"},{"key":"2025121223531995000_4.9.e005265.28","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199711000-00002"},{"key":"2025121223531995000_4.9.e005265.29","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(82)90024-1"},{"key":"2025121223531995000_4.9.e005265.30","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1137"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2014-005265","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:53:27Z","timestamp":1765612407000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2014-005265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":30,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,9,4]]},"published-print":{"date-parts":[[2014,9]]}},"alternative-id":["10.1136\/bmjopen-2014-005265"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2014-005265","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}